Trials / Unknown
UnknownNCT05055375
The Psychology of Chinese Breast Cancer Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Ma Fei，MD · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Earlier diagnosis of breast cancer in women and the use of systemic adjuvant therapy have increased the likelihood of long term, disease free survival.women who remain free of breast cancer seem to have levels of functioning and quality of life that are comparable to those of the general female population.It will be assessed the psychology status of women with breast cancer using a clinical interview,
Detailed description
It conducts a questionnaire survey of 300 patients. The questionnaires used are: Psychological Pain Thermometer DT, Hospital Anxiety and Depression Scale HADS, Quality of Life Scale for Breast Cancer Patients FACT-B, Social Support Rating Scale SSRS. Caregivers should fill in the following scales: Psychological Pain Thermometer DT, Hospital Anxiety and Depression Scale HADS, Caregiver Burden Assessment Scale ZBI. Inclusion criteria: 1,female patients with early breast cancer after surgery; 2,no previous mental and psychological abnormalities; 3,Postoperative and prepare to accept adjuvant chemotherapy ; 4,Patient's know her/his illness . To explore: 1. Psychological status and dynamic changes of patients and caregivers during adjuvant chemotherapy after breast cancer surgery in China. 2. The influence of psychological status of Chinese breast cancer patients on adverse reactions during adjuvant chemotherapy. 3. Gene susceptibility to psychological abnormalities during adjuvant chemotherapy for breast cancer in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questionnaire survey | We will conduct a questionnaire survey of outpatients. |
Timeline
- Start date
- 2019-04-25
- Primary completion
- 2020-12-31
- Completion
- 2021-12-31
- First posted
- 2021-09-24
- Last updated
- 2021-09-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05055375. Inclusion in this directory is not an endorsement.